The Obalon Balloon System is the FIRST and ONLY swallowable, FDA-approved balloon treatment option for weight loss. The lightweight balloons occupy space in the stomach so people eat less, which makes weight loss easier. The non-surgical treatment lasts 6-months and is coupled with a professionally supervised nutrition and exercise program. Contact our office for complete and further information on the Obalon Balloon System!
How does the Obalon Balloon System work?
The Obalon Balloon System helps facilitate weight loss by taking up space in their stomach so people east less. During treatment people receive professional nutrition and exercise support to help make the lifestyle changes that facilitate weight loss. The Obalon Balloon System provides support to help change eating habits and keep the weight off for the long-term.
What commitment is required?
The Obalon Balloon System can assist with weight loss efforts, but weight loss success is also dependent on people’s readiness to develop new lifestyle skills. The degree of long-term weight loss will depend on their ability to modify their lifestyle and maintain this behavior after the balloons are removed. It is important that you discuss their willingness to accept this commitment before treating them with the Obalon Balloon System.
What weight loss results can be expected?
In a large clinical study, the Obalon Balloon System was shown to help adults have clinically meaningful weight loss. When used with a diet and exercise program people lost on average 15 pounds and up to 50 pounds. An average of 89.5% of the total weight loss was maintained at 1 year.
How long is the treatment?
The Obalon Balloon treatment is a 6-month treatment. People usually have a second balloon 1 month after the first balloon and a third balloon 2 months after the second balloon. All balloons will be taken out 6 months after the first balloon capsule was swallowed.
What are the potential side effects of the Obalon Balloon System?
The Obalon Balloon System is a safe, effective, FDA-approved, non-surgical weight loss system. In the clinical trial, the majority of adverse events were reported as mild and consisted of abdominal pain and nausea which typically resolve within two weeks. (serious side effects were less than 0.3%). You can find this information and a complete list of contradictions warnings and precautions by clicking here.
c 2016 Obalon Therapeutics Inc. LIT-7500-0037-01. November 2016.